Mind Medicine (MindMed) Inc. (MNMD)
NASDAQ: MNMD · Real-Time Price · USD
7.26
0.00 (0.00%)
At close: May 30, 2025, 4:00 PM
7.39
+0.13 (1.79%)
Pre-market: Jun 2, 2025, 8:59 AM EDT
Mind Medicine (MindMed) Market Cap
Mind Medicine (MindMed) has a market cap or net worth of $548.52 million as of June 2, 2025. Its market cap has decreased by -10.11% in one year.
Market Cap
548.52M
Enterprise Value
358.11M
1-Year Change
-10.11%
Ranking
Category
Stock Price
$7.26
Market Cap Chart
Since March 4, 2020, Mind Medicine (MindMed)'s market cap has decreased from $595.37M to $548.52M, a decrease of -7.87%. That is a compound annual growth rate of -1.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 548.52M | 7.47% |
| Dec 31, 2024 | 510.39M | 247.80% |
| Dec 29, 2023 | 146.75M | 77.54% |
| Dec 30, 2022 | 82.66M | -85.99% |
| Dec 31, 2021 | 590.17M | -82.89% |
| Dec 31, 2020 | 3.45B | 479.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |